CI Investments Inc
IDXX icon

CI Investments Inc’s Idexx Laboratories IDXX Stock Holding History

CI Investments Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
6,187
+5,264
+570% +$2.95M 0.01% 405
2026
Q1 		$519K Sell
923
-15
-2% -$9.62K ﹤0.01% 479
2025
Q4 		$635K Buy
938
+43
+5% +$29.3K ﹤0.01% 471
2025
Q3 		$572K Sell
895
-427
-32% -$259K ﹤0.01% 497
2025
Q2 		$709K Sell
1,322
-80
-6% -$38.3K ﹤0.01% 477
2025
Q1 		$589K Sell
1,402
-821
-37% -$356K ﹤0.01% 499
2024
Q4 		$919K Buy
2,223
+182
+9% +$79.8K ﹤0.01% 429
2024
Q3 		$1.03M Sell
2,041
-161
-7% -$78.2K ﹤0.01% 407
2024
Q2 		$1.07M Sell
2,202
-192
-8% -$96.4K ﹤0.01% 386
2024
Q1 		$1.29M Buy
2,394
+1,020
+74% +$557K 0.01% 370
2023
Q4 		$763K Sell
1,374
-234
-15% -$110K ﹤0.01% 392
2023
Q3 		$703K Sell
1,608
-221
-12% -$110K ﹤0.01% 398
2023
Q2 		$919K Buy
1,829
+894
+96% +$428K ﹤0.01% 380
2023
Q1 		$468K Buy
935
+584
+166% +$279K ﹤0.01% 442
2022
Q4 		$143K Buy
351
+121
+53% +$47K ﹤0.01% 673
2022
Q3 		$75K Buy
230
+99
+76% +$36.4K ﹤0.01% 752
2022
Q2 		$46K Sell
131
-1,684
-93% -$687K ﹤0.01% 842
2022
Q1 		$993K Sell
1,815
-74
-4% -$38.9K ﹤0.01% 435
2021
Q4 		$1.24M Buy
1,889
+405
+27% +$254K ﹤0.01% 427
2021
Q3 		$923K Buy
1,484
+255
+21% +$171K ﹤0.01% 467
2021
Q2 		$776K Buy
1,229
+86
+8% +$47.5K ﹤0.01% 525
2021
Q1 		$559K Sell
1,143
-1,032
-47% -$517K ﹤0.01% 523
2020
Q4 		$1.09M Buy
2,175
+1,034
+91% +$463K ﹤0.01% 377
2020
Q3 		$449K Sell
1,141
-335
-23% -$124K ﹤0.01% 429
2020
Q2 		$487K Sell
1,476
-450
-23% -$130K ﹤0.01% 394
2020
Q1 		$467K Sell
1,926
-59
-3% -$15.4K ﹤0.01% 394
2019
Q4 		$518K Sell
1,985
-128
-6% -$33.7K ﹤0.01% 447
2019
Q3 		$575K Buy
+2,113
New +$588K ﹤0.01% 434

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

CI Investments Inc's IDXX Position: Q2 2026 in Review

CI Investments Inc increased its Idexx Laboratories (IDXX) stake by 570% in Q2 2026, buying an estimated $2.95M and bringing the position to 6,187 shares worth $3.26M. The position accounts for 0.01% of the portfolio, ranked #405.

CI Investments Inc first reported a position in IDXX in Q3 2019 and has held it in 28 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • CI Investments Inc held 6,187 shares of Idexx Laboratories worth $3.26M as of Q2 2026.
  • CI Investments Inc bought 5,264 Idexx Laboratories shares in Q2 2026, an estimated $2.95M.
  • Idexx Laboratories made up 0.01% of CI Investments Inc's portfolio in Q2 2026, its #405 holding.
  • CI Investments Inc first reported a position in Idexx Laboratories in Q3 2019 and has held it in 28 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.